XM does not provide services to residents of the United States of America.

BTG Pactual gets green light to buy AccorInvest hotels in Brazil for $300 mln



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BTG Pactual gets green light to buy AccorInvest hotels in Brazil for $300 mln</title></head><body>

By Luciana Magalhaes

SAO PAULO, Oct 21 (Reuters) -Funds managed by Brazilian investment bank BTG Pactual BPAC11.SA received preliminary approval on Friday from the country´s antitrust regulator to buy the hotel operations of AccorInvest in Brazil for 1.7 billion reais ($300 million), regulatory documents showed on Monday.

Funds from BTG are acquiring all 18 hotels AccorInvest owns in Brazil, totaling 2,600 rooms, three people familiar with the deal said.

The hotels will be distributed into three funds managed by BTG, the same people said, adding that the 1.7 billion reais also comprises investments in the properties. The hotels will continue to be operated by Accor, they added.

The new portfolio includes the Fairmont Copacabana and the former Caesar Park, renamed under the Sofitel brand, both in Rio de Janeiro, the sources said.

Once the preliminary approval is given, commissioners from the regulator, known as Cade, and interested parties have up to 15 days to challenge the deal.

With this deal, funds managed by BTG will own 54 hotels with approximately 4,300 rooms in Brazil, mainly in the states of Sao Paulo and Rio de Janeiro, the sources said.

AccorInvest and BTG declined to comment on the deal.

BTG, which has been in talks with Accor since the beginning of the year, intends to finalize the acquisition by the end of 2024, one of the people told Reuters.

The funds involved in the transaction will now concentrate on the closing of the deal, but see future opportunities in the hotel segment in Brazil, according to the same people.

BTG funds have $5.5 billion in assets under management in the real estate sector, most of it in Brazil, the people said.



Reporting by Luciana Magalhaes in Sao Paulo; Editing by Mark Porter

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.